GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we treat type 2 diabetes . These new medications function to mimicking the body’s natural GLP-1 https://bacteriastatic-water048968.goabroadblog.com/profile